Fig. 4From: NEAT1 can be a diagnostic biomarker in the breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: integrated RNA targetome interaction and experimental expression analysisRelative expression analysis of NEAT1 in the breast cancer samples revealed that NEAT1 expression levels have a significant down-regulation in the breast cancer samples with tumor size lower than 2 cm, compared to the samples with bigger tumor sizeBack to article page